IDRA - イデラ・ファ―マシュ―ティカルズ (Idera Pharmaceuticals Inc.) イデラ・ファ―マシュ―ティカルズ

 IDRAのチャート


 IDRAの企業情報

symbol IDRA
会社名 Idera Pharmaceuticals Inc (イデラ・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 イデラ・ファーマシューティカルズ(Idera Pharmaceuticals Inc.)は腫瘍学及び希少疾患の治療薬の発見・開発・商業化に焦点を当てた臨床段階のバイオ医薬企業である。同社はトール様受容体(TLR)ターゲティング技術および第3世代アンチセンス(3GA)技術を含む薬物候補を設計・開発するために、2つの創薬技術プラットフォームを利用する。TLR技術を使用して、同社は特定のTLRの活性を調節することによって作用する合成オリゴヌクレオチドに基づく薬物候補を設計する。3GA技術を用いて、病気を引き起こす遺伝子に関連するメッセンジャーリボ核酸(mRNA)をオフにする薬剤候補を開発する。同社の薬物候補には、IMO-8400、IMO-2125およびIMO-9200が含まれる。同社は、TLRアンタゴニストおよびアゴニストを、標的化TLRの活性を調節することによって作用させるように設計した。同社は病気を引き起こす遺伝子に関連するmRNAを消す3GA技術を開発する。   イデラ・ファ―マシュ―ティカルズは、臨床段階の米国バイオテクノロジ―企業。自己免疫疾患の治療のためと特定の遺伝的に定義されたフォ―ムのB細胞リンパ腫の治療製薬の開発に従事する。癌、感染症やアルツハイマ―病などの分野でTLR7、TLR8、およびTLR9作用薬を含むワクチンの製品を、研究・開発、商業化する。   Harnessing the approach of the earliest researchers in immunotherapy and the company's vast experience in developing proprietary immunology platforms, Idera's development program is focused on priming the immune system to play a more powerful role in fighting cancer, ultimately increasing the number of people who can benefit from immunotherapy. Idera also continues to focus on the acquisition, development, and ultimate commercialization of drug candidates for both oncology and rare disease indications characterized by small, well-defined patient populations with serious unmet needs.
本社所在地 167 Sidney Street Cambridge MA 02139 USA
代表者氏名 James A. Geraghty ジェームズ・A.グラガッティ
代表者役職名 Independent Chairman of the Board
電話番号 +1 484-348-1600
設立年月日 32629
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数
url www.iderapharma.com
nasdaq_url https://www.nasdaq.com/symbol/idra
adr_tso
EBITDA EBITDA(百万ドル) -65.52800
終値(lastsale) 8.71
時価総額(marketcap) 236684259.63
時価総額 時価総額(百万ドル) 191.30390
売上高 売上高(百万ドル) 0.75500
企業価値(EV) 企業価値(EV)(百万ドル) 97.25790
当期純利益 当期純利益(百万ドル) -65.58200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Idera Pharmaceuticals Inc revenues decreased 26% to $418K. Net loss decreased 1% to $36.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and development decrease of 17% to $24.4M (expense) Interest income increase of 62% to $482K (income).

 IDRAのテクニカル分析


 IDRAのニュース

   May This Data Fuel Up Investors Confidence? Oracle Corporation (NYSE:ORCL), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/07/20 22:23:32 Stock Equity
Oracle Corporation (NYSE:ORCL) with the stream of 1.90% also noticed, India Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) encountered a rapid change of -1.94% in the last hour of Tuesdays trading session. Oracle The post May This Data Fuel Up Investors Confidence? Oracle Corporation (NYSE:ORCL), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   Todays Hot Mover: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/07/19 23:35:16 Stock Equity
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) with the stream of -2.78% also noticed, India Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) encountered a rapid change of -2.20% in the last hour of Mondays trading session. The post Todays Hot Mover: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   Sharp Percentage Decline Stock: iQIYI, Inc. (NASDAQ:IQ), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/07/14 23:00:56 Stock Equity
iQIYI, Inc. (IQ) with the stream of -4.08% also noticed, India Idera Pharmaceuticals, Inc. (IDRA) encountered a rapid change of -3.60% in the last hour of Wednesdays trading session. iQIYI, The post Sharp Percentage Decline Stock: iQIYI, Inc. (NASDAQ:IQ), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   May This Data Fuel Up Investors Confidence? United Airlines Holdings, Inc. (NASDAQ:UAL), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/07/09 23:54:33 Stock Equity
United Airlines Holdings, Inc. (UAL) with the stream of 3.16% also noticed, India Idera Pharmaceuticals, Inc. (IDRA) encountered a rapid change of 2.69% in the last hour of Fridays trading The post May This Data Fuel Up Investors Confidence? United Airlines Holdings, Inc. (NASDAQ:UAL), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   ATR Oversold/Overbought Signals to Track: Apple Inc. (NASDAQ:AAPL), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/07/08 22:35:10 Stock Equity
Apple Inc. (AAPL) with the stream of -0.93% also noticed, India Idera Pharmaceuticals, Inc. (IDRA) encountered a rapid change of 0.91% in the last hour of Thursdays trading session. Apple The post ATR Oversold/Overbought Signals to Track: Apple Inc. (NASDAQ:AAPL), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   Thinking about buying stock in Biocept, Histogen, Idera Pharmaceuticals, Satsuma Pharmaceuticals, or Clover Health Investments?  2021/06/22 13:31:00 Benzinga
NEW YORK , June 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOC, HSTO, IDRA, STSA, and CLOV. Full story available on Benzinga.com
   Sanderson Farms, GameStop among notable premarket gainers  2021/06/22 12:21:14 Seeking Alpha
   Volatile Movements: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Palatin Technologies, Inc. (AMEX:PTN)  2021/06/18 22:59:23 Stock Equity
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) with the stream of -3.25% also noticed, India Palatin Technologies, Inc. (AMEX:PTN) encountered a rapid change of -1.17% in the last hour of Fridays trading session. The post Volatile Movements: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Palatin Technologies, Inc. (AMEX:PTN) appeared first on Stocks Equity .
   Project Future Performance Before Investment: Onconova Therapeutics, Inc. (NASDAQ:ONTX), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/06/09 21:40:19 Stock Equity
Onconova Therapeutics, Inc. (NASDAQ:ONTX) with the stream of 15.59% also noticed, India Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) encountered a rapid change of -1.34% in the last hour of trading session. Onconova The post Project Future Performance Before Investment: Onconova Therapeutics, Inc. (NASDAQ:ONTX), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   DOCU, CLNE, KNDI and SENS among premarket gainers  2021/06/04 12:21:16 Seeking Alpha
   Volatile Movements: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Palatin Technologies, Inc. (AMEX:PTN)  2021/06/18 22:59:23 Stock Equity
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) with the stream of -3.25% also noticed, India Palatin Technologies, Inc. (AMEX:PTN) encountered a rapid change of -1.17% in the last hour of Fridays trading session. The post Volatile Movements: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Palatin Technologies, Inc. (AMEX:PTN) appeared first on Stocks Equity .
   Project Future Performance Before Investment: Onconova Therapeutics, Inc. (NASDAQ:ONTX), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)  2021/06/09 21:40:19 Stock Equity
Onconova Therapeutics, Inc. (NASDAQ:ONTX) with the stream of 15.59% also noticed, India Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) encountered a rapid change of -1.34% in the last hour of trading session. Onconova The post Project Future Performance Before Investment: Onconova Therapeutics, Inc. (NASDAQ:ONTX), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) appeared first on Stocks Equity .
   DOCU, CLNE, KNDI and SENS among premarket gainers  2021/06/04 12:21:16 Seeking Alpha
   Idera Pharma rises as insider raises stake  2021/06/03 20:49:47 Seeking Alpha
   The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation  2021/05/23 14:05:56 Benzinga
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. The American Society of Clinical Oncology, which is set to hold its meeting June 4-8, published abstracts submitted by presenters at the conference. These abstracts triggered some stock-specific reactions. The week witnessed a few top-level executive departures. Cancer biotech Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ) lost its chief medical officer. Gene therapy company Passage Bio, Inc. (NASDAQ: PASG ) announced the departure of its CMO, while it said its chief financial officer will also leave by this month''s end. Voyager Therapeutics, Inc.''s (VYGR) chief executive officer and CMO called it quits , with the company announcing renewed focus on TRACERT gene therapy technology platform and next-generation targeted AAV capsids . Moderna, Inc. (NASDAQ: MRNA ) said its COVID-19 vaccine was approved for emergency use in Japan, while Pfizer, Inc.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 イデラ・ファ―マシュ―ティカルズ IDRA Idera Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)